PDF
(Download)
|
- Green Tea (Camellia sinensis)
- Hypertension
- Insulin Resistance
|
Date:
11-27-2013 | HC# 061357-485
|
Re: Green Tea Supplementation Improves Cardiovascular Risk Factors
Bogdanski
P, Suliburska J, Szulinska M, Stepien M, Pupek-Musialik D, Jablecka A. Green
tea extract reduces blood pressure, inflammatory biomarkers, and oxidative
stress and improves parameters associated with insulin resistance in obese,
hypertensive patients. Nutr Res.
2012;32(6):421-427.
Obesity,
hypertension, oxidative stress, chronic low-grade inflammatory response,
endothelial dysfunction in cardiovascular disease, and progression of insulin
resistance are all interrelated. Green tea (Camellia
sinensis) extract and its catechin epigallocatechin-3-gallate (EGCG) have
anti-inflammatory and antioxidant effects, which may improve insulin resistance
and associated cardiovascular risk factors. Hence, the purpose of this
randomized, double-blind, placebo-controlled, parallel-design study was to evaluate
the effect of green tea extract on insulin resistance and associated cardiovascular
risk factors in obese patients with hypertension.
Patients
(n = 56, aged 30-60 years) were recruited from the outpatient clinic at Poznań
University of Medical Sciences; Poznań, Poland. The chosen subjects had a body
mass index (BMI) ≥ 30 kg/m2, stable body weight, and well-controlled
arterial hypertension (systolic blood pressure [SBP] < 160 mmHg and/or diastolic
blood pressure [DBP] < 100 mmHg with stable treatment for ≥ 6 months).
Patients were excluded for having secondary hypertension; secondary obesity
(medical condition that causes weight gain); diabetes; history of coronary
artery disease; stroke; congestive heart failure; malignancies; history of use
of any dietary supplements within 3 months before the study; current need for modification
of antihypertensive therapy; abnormal liver, kidney, or thyroid gland function;
clinically significant inflammatory process within respiratory, digestive, or genitourinary
tract, or in the oral cavity, pharynx, or paranasal sinuses; history of
infection in the month before the study; and nicotine or alcohol abuse.
Patients
received placebo or 379 mg green tea extract (containing 208 mg EGCG; Olimp
Labs; Dębica, Poland) for 3 months. They were instructed to maintain their
current diet and exercise. BMI, waist circumference, blood pressure, and blood
samples were taken at baseline and after 3 months of treatment. Blood was
analyzed for insulin resistance (homeostasis model assessment of insulin resistance
[HOMA-IR]), high-sensitivity C-reactive protein (hs-CRP), tumor necrosis factor-alpha
(TNF-α), total antioxidant status, total cholesterol, low-density lipoprotein (LDL)
cholesterol, high-density lipoprotein (HDL) cholesterol, triglycerides (TGs),
creatinine, and fasting glucose. Every 14 days and also 3 days before the
laboratory tests, dietary intake was determined via dietary intake interviews
(24-hour recall).
There
were no significant differences between groups at baseline. Compared with
baseline, 3 months of treatment with green tea extract significantly reduced
SBP (P = 0.004), DBP (P < 0.001), total cholesterol (P = 0.009), LDL cholesterol
(P = 0.011), TGs (P = 0.004), glucose (P = 0.016), insulin (P < 0.001),
HOMA-IR (P = 0.009), TNF-α (P < 0.001), and CRP (P < 0.001), and there
were significant increases in HDL cholesterol (P < 0.001) and total
antioxidant status (P < 0.001). In contrast, the placebo group did not have
any significant changes compared with baseline. However, when comparing the
change from baseline between the 2 treatment groups, there was a significant
difference between the green tea group and the placebo group for SBP (P <
0.001), DBP (P < 0.001), total cholesterol (P < 0.001), LDL cholesterol
(P = 0.022), HDL cholesterol (P = 0.023), TGs (P < 0.001), insulin (P =
0.005), HOMA-IR (P = 0.004), TNF-α (P < 0.001), CRP (P < 0.001), and
total antioxidant status (P < 0.001). Both BMI and waist circumference did
not change significantly during the study.
The
authors conclude that 3 months of treatment with green tea extract had
significant influence on cardiovascular risk factors such as insulin
resistance, blood pressure, inflammation, and oxidative stress in this patient
population. The findings of this study are supported by preclinical studies in
animals. Additional studies are needed to evaluate the longer-term effects of
green tea extract, and a study with a larger number of participants is needed
to confirm the findings.
—Heather S. Oliff,
PhD
|